Nuvalent Inc vs Nasdaq100 ETF — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Nasdaq100 ETF trades at $709.2. The key difference: Nuvalent Inc is trading nearer its 52-week high, Nasdaq100 ETF nearer its low. Which is the better fit depends on your goals.
| NUVL | QQQ | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | — |
52-Week High | $123.96 | $746.16 |
52-Week Low | $72.16 | $553.88 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →